Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
Cancer diagnostics developer Syantra said Wednesday that it has raised C$4.9 million (US$3.6 million) in a Series A-1 financing round.
Entos Pharmaceuticals Receives Approval from Health Canada to Begin Clinical Trial for COVID-19 Vaccine Booster
Nanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes accessible to men in British Columbia, Saskatchewan, and Ontario
SciencePak™ partners with Alexander Chemical L.P., to produce and distribute a range of chemical and life sciences products and services.
Discover Why Health Professionals Trust NanoSALV Catalytic from NanoTess – a Novel, Cost-Effective Canadian Wound Care Technology